Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Excedrin sampling

This article was originally published in The Tan Sheet

Executive Summary

Novartis is linking its Excedrin to the equity of "Go" and its message of "The Pain Stops. You Don't." in its most recent advertising and marketing campaign for the headache reliever, the company states. In addition to launching new print and TV advertising spots, the firm has initiated a sampling program that "engages our target audience at lifestyle-appropriate venues and locations," Novartis states. The firm is targeting consumers that "meet our demographic of active lifestyles" at "on the go" locations venues including cruise ships, health clubs and coffee shops as well as commuter and college sampling. Novartis acquired Excedrin as part of its purchase of Bristol-Myers Squibb's Canadian Consumer Medicines business in September 2005 (1"The Tan Sheet" Sept. 5, 2005, In Brief)...
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS099695

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel